Causal gene-to-circuit models from in vivo CRISPR atlases
PerturbAI Engine powers drug-discovery workflows with organism-scale CRISPR perturbation atlases that link genes to cells, circuits and disease. The product trains biological AI models intended to predict how genes and drugs reshape living systems, supporting target discovery and therapeutic hypothesis generation.